OUR RECENT RESEARCH
Scheer CS et al. Blood culture practices and microbiological capacity for sepsis diagnostics in Europe (2021–2022): a cross-sectional analysis of the European Sepsis Care Survey The Lancet Regional Health - Europe Volume 62, March 2026, 101570
Cordovana M, Kostrzewa M, Bohnert JA, Eger E, Hübner NO, Becker K, Schaufler K, Heiden SE, Idelevich EA. Fourier-transform infrared spectroscopy reliably differentiates Klebsiella pneumoniae outbreak isolates. J Microbiol Methods. 2025; 240: 107355
Idelevich EA, Schlattmann A, Sauerland C, Gebert C, Becker K. Antimicrobial activity of copper-nickel coated door handles: a blinded, randomized controlled study in a clinical setting. GMS Hyg Infect Control. 2025;20:Doc47
Doğan E, Schaufler K, Heiden SE, Kohler C, Langheinrich M, Becker K, Eger E, Idelevich EA. Prevalence, characteristics and clinical features of hypervirulent Klebsiella pneumoniae in a German university hospital. Int J Med Microbiol. 2025; 320: 151662
Sydow K, Doğan E, Schwabe M, Heiden SE, Khan MM, Müller JU, Bohnert JA, Baecker D, Schlüter R, Schierack P, Eger E, Idelevich EA, Becker K, Schaufler K. Potential in-host evolution of Klebsiella pneumoniae ST147: convergence and the role of capsular alterations in morphotype diversity. Microbiol Spectr. 2025: e0017025
Idelevich EA, Becker K. Phagenendolysine – eine neue Wirkstoffklasse mit vielfältigen Einsatzmöglichkeiten. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2025; 68: 660-669
Scheer CS et al. Status of sepsis care in European hospitals: Results from an international cross-sectional survey. Am J Respir Crit Care Med. 2025; 211: 587-599
